C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

Danesh, John, Wheeler, Jeremy G., Hirschfield, Gideon M., Eda, Shinichi, Eiriksdottir, Gudny, Rumley, Ann, Lowe, Gordon D.O., Pepys, Mark B. +1 more·2004·New England Journal of Medicine

Cited by (1,014)

Items 101–200 of 1,014

  1. Erratum: Inflammatory processes in cardiovascular disease: a route to targeted therapies
    Neil Ruparelia, Joshua T. Chai, Edward A A Fisher, Robin P. Choudhury · 2017 · Nature Reviews Cardiology
  2. Short sleep duration and cardiometabolic risk: from pathophysiology to clinical evidence
    Tobaldini, Eleonora, Fiorelli, Elisa M., Solbiati, Monica, Costantino, Giorgio, Nobili, Lino, Montano, Nicola · 2019 · Nature Reviews Cardiology
  3. Mechanisms of Disease: atherosclerosis in autoimmune diseases
    Yaniv Sherer, Yehuda Shoenfeld · 2006 · Nature Clinical Practice Rheumatology
  4. Low serum albumin: A neglected predictor in patients with cardiovascular disease
    Antonis S. Manolis, Theodora A. Manolis, Helen Melita, Dimitri P. Mikhailidis, Antonis S. Manolis · 2022 · European Journal of Internal Medicine
  5. Nitric Oxide in Hypertension
    Matthias Hermann, Andreas J. Flammer, Thomas Felix Lüscher · 2006 · Journal of Clinical Hypertension
  6. An Assessment of Incremental Coronary Risk Prediction Using C-Reactive Protein and Other Novel Risk Markers
    Aaron R. Folsom, Lloyd E. Chambless, Christie Mitchell Ballantyne, Josef Coresh, Gerardo M HEISS, Kenneth K. Wu, Eric Boerwinkle, Thomas H. Mosley, Paul D. Sorlie, Guoqing Diao et al. · 2006 · Archives of Internal Medicine
  7. C-Reactive Protein Levels, Variation in the C-Reactive Protein Gene, and Cancer Risk: The Rotterdam Study
    Claire Siemes, Loes E. Visser, J.W.W. Coebergh, Ted A.W. Splinter, Jacqueline C.M. Witteman, André Gerardus Uitterlinden, Albert Hofman D, Huibert A. P. Pols, Bruno H. Ch. Stricker · 2006 · Journal of Clinical Oncology
  8. Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis
    Teeranan Angkananard, Thunyarat Anothaisintawee, Mark McEvoy, John Attia, Ammarin Thakkinstian · 2018 · BioMed Research International
  9. Stress and Inflammation in Coronary Artery Disease: A Review Psychoneuroendocrineimmunology-Based
    Massimo Fioranelli, Anna Giulia Bottaccioli, Francesco Bottaccioli, Maria Bianchi, Miriam Rovesti, Maria Grazia Roccia · 2018 · Frontiers in Immunology
  10. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study
    Nicholas John Timpson, Debbie A. Lawlor, Roger M. Harbord, Tom R. Gaunt, Ian N.M. Day, Lyle John Palmer, Andrew Tym Hattersley, Shah B J Ebrahim, Gordon D O Lowe, Ann Rumley et al. · 2005 · The Lancet
  11. von Willebrand factor, endothelial dysfunction, and cardiovascular disease
    Ulrich M. Vischer · 2006 · Journal of Thrombosis and Haemostasis
  12. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study
    de Ruijter, W., Westendorp, R. G J, Assendelft, W. J J, den Elzen, W. P J, de Craen, A. J M, le Cessie, S., Gussekloo, J. · 2009 · BMJ
  13. C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients
    Sotirios Tsimikas, James T. Willerson, Paul M. Ridker · 2006 · Journal of the American College of Cardiology
  14. Association of high-sensitivity C-reactive protein with <i>de novo</i> major depression
    Pasco, Julie A., Nicholson, Geoffrey C., Williams, Lana J., Jacka, Felice N., Henry, Margaret J., Kotowicz, Mark A., Schneider, Hans G., Leonard, Brian E., Berk, Michael · 2010 · British Journal of Psychiatry
  15. Childhood adversity and inflammatory processes in youth: a prospective study
    Slopen, Natalie, Kubzansky, Laura D., McLaughlin, Katie A., Koenen, Karestan C. · 2013 · Psychoneuroendocrinology
  16. Polymorphisms within the C-Reactive Protein (CRP) Promoter Region Are Associated with Plasma CRP Levels
    Christopher S. Carlson, Shelley Force Aldred, Philip Kenneth Lee, Russell P. Tracy, Stephen M. Schwartz, Mark J. Rieder, Kiang Liu, O. Dale Williams, Carlos Iribarren, E. Cora Lewis et al. · 2005 · The American Journal of Human Genetics
  17. C-Reactive Protein in Atherothrombosis and Angiogenesis
    Lina Badimón, Esther Peña, Gemma Arderiu, Teresa Padró, MARK A. SLEVIN, Gemma Vilahur, Gemma Chiva‐Blanch · 2018 · Frontiers in Immunology
  18. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy
    Koenig, Wolfgang · 2013 · International Journal of Cardiology
  19. Markers of Systemic Bacterial Exposure in Periodontal Disease and Cardiovascular Disease Risk: A Systematic Review and Meta‐Analysis
    Indra Z. Mustapha, Sarah M. Debrey, Michael Oladubu, Richard M. Ugarte · 2007 · Journal of Periodontology
  20. Cardiometabolic Aspects of the Polycystic Ovary Syndrome
    Harpal Singh Randeva, Bee Kang Tan, Martin O. Weickert, Konstantinos B. Lois, John E. Nestler, Naveed A. Sattar, Hendrik Lehnert · 2012 · Endocrine Reviews
  21. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities
    Pope, Janet E., Choy, Ernest H. · 2021 · Seminars in Arthritis and Rheumatism
  22. Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis
    S. Goya Wannamethee, Gordon D O Lowe, Ann Rumley, K. Richard Bruckdorfer, Peter Hynes Whincup · 2006 · American Journal of Clinical Nutrition
  23. Inflammation in Peripheral Artery Disease
    Gregorio Brevetti, Giuseppe Giugliano, Linda Brevetti, William R. Hiatt · 2010 · Circulation
  24. Physical activity and health
    Lisa M Miles · 2007 · Nutrition Bulletin
  25. Carotid Intima-Media Thickness for Atherosclerosis
    Tomohisa Nezu, Naohisa Hosomi, Shiro Aoki, Masayasu Matsumoto · 2015 · Journal of Atherosclerosis and Thrombosis
  26. Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and Atherosclerosis
    Hidenori Koyama, Takuhito Shoji, Hisayo Yokoyama, Kohka Motoyama, Katsuhito Mori, Shinya Fukumoto, Masanori Emoto, Tetsuo Shoji, Hironori Tamei, Hirokazu Matsuki et al. · 2005 · Arteriosclerosis Thrombosis and Vascular Biology
  27. Saturated and Polyunsaturated Fatty Acids Reciprocally Modulate Dendritic Cell Functions Mediated through TLR4
    Amy R. Weatherill, Joo Young Lee, Ling Zhao, Danielle G. Lemay, Hyung Sun Youn, Daniel H. Hwang · 2005 · The Journal of Immunology
  28. Assessment of Conventional Cardiovascular Risk Factors and Multiple Biomarkers for the Prediction of Incident Heart Failure and Atrial Fibrillation
    J. Gustav Smith, Christopher Newton‐Cheh, Peter Almgren, Joachim Struck, Nils G. Morgenthaler, Andreas Bergmann, Pyotr G. Platonov, Bo Hedblad, Gunnar Engström, Thomas J. Wang et al. · 2010 · Journal of the American College of Cardiology
  29. The Metabolic Syndrome and Concentrations of C-Reactive Protein Among U.S. Youth
    Earl S. Ford, Umed A. Ajani, Ali H. Mokdad · 2005 · Diabetes Care
  30. Personalized protein corona on nanoparticles and its clinical implications
    Claudia Corbo, Roberto Molinaro, Mateen Tabatabaei, Omid Cameron Farokhzad, Morteza Mahmoudi · 2017 · Biomaterials Science
  31. Chronic Inflammatory Disorders and Risk of Type 2 Diabetes Mellitus, Coronary Heart Disease, and Stroke: A Population-Based Cohort Study
    Dregan, Alex, Charlton, Judith, Chowienczyk, Phil, Gulliford, Martin C. · 2014 · Circulation
  32. Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses
    F. Crispi, Edgar A. Hernandez‐Andrade, Maurice M. A. L. Pelsers, Walter Plasencia, Jesús Andrés Benavides-Serralde, E. Eixarch, Ferdinand A. C. le Noble, Asif Ahmed, Jan F. C. Glatz, Kypros H. Nicolaides et al. · 2008 · American Journal of Obstetrics and Gynecology
  33. Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease
    Salas-Salvadó, J, Garcia-Arellano, A, Estruch, R, Marquez-Sandoval, F, Corella, D, Fiol, M, Gómez-Gracia, E, Viñoles, E, Arós, F, Herrera, C et al. · 2008 · European Journal of Clinical Nutrition
  34. Significance of a Multiple Biomarkers Strategy Including Endothelial Dysfunction to Improve Risk Stratification for Cardiovascular Events in Patients at High Risk for Coronary Heart Disease
    Toshimitsu Nozaki, Seigo Sugiyama, Hidenobu Koga, Koichi Sugamura, Keisuke Ohba, Yasushi Matsuzawa, Hitoshi Sumida, Kunihiko Matsui, Hideaki Jinnouchi, Hisao Ogawa · 2009 · Journal of the American College of Cardiology
  35. Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction
    Thomas J. Wang · 2011 · Circulation
  36. Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
    Claes Held, Harvey Douglas White, Ralph Stewart, Andrzej Budaj, Christopher Paul Cannon, Judith S. Hochman, Wolfgang Köenig, Agneta G Siegbahn, Philippe Gabríel Steg, Joseph Soffer et al. · 2017 · Journal of the American Heart Association
  37. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis
    Katriina Heikkilä, Ross Harris, Gordon D O Lowe, Ann Rumley, John Yarnell, John Gallacher, Yoav Ben‐Shlomo, Shah B J Ebrahim, Debbie A. Lawlor · 2008 · Cancer Causes & Control
  38. Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies
    Nazmi, Aydin, Victora, Cesar G · 2007 · BMC Public Health
  39. Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke
    Mario Di Napoli, Markus Schwaninger, Roberto Cappelli, Elena Ceccarelli, Giacinto Di Gianfilippo, Cristina Donati, Hedley C A Emsley, Sandro Forconi, Stephen J. Hopkins, Luca Masotti et al. · 2005 · Stroke
  40. Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels
    Victor Aboyans, Michael H. Criqui, Julie O. Denenberg, James D. Knoke, Paul M. Ridker, Arnost S. Fronek · 2006 · Circulation
  41. Prognostic and Pathogenetic Value of Combining Clinical and Biochemical Indices in Patients With Acute Lung Injury
    Lorraine B. Ware, Tatsuki Koyama, Dean D. Billheimer, William Ka Kei Wu, Gordon R. Bernard, Bruce Thompson, Roy G. Brower, Theodore J. Standiford, Thomas R. Martin, Michael A. Matthay · 2009 · CHEST Journal
  42. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
    Ian D. Graham, Dan Atar, Knut Borch‐Johnsen, Gudrun Boysen, Gunilla K Burell, Renata Cífková, Jean Dallongeville, Guy De Backer, Shah B J Ebrahim, Bjørn Gjelsvik et al. · 2007 · European Journal of Cardiovascular Prevention & Rehabilitation
  43. Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease&lt;subtitle&gt;Large-Scale Prospective Data&lt;/subtitle&gt;
    Bennet, Anna · 2008 · Archives of Internal Medicine
  44. Virchow’s Triad Revisited: Abnormal Flow
    Gordon D O Lowe · 2003 · Pathophysiology of Haemostasis and Thrombosis
  45. Nature's randomised trials
    Aroon Dinesh Hingorani, Steve Eric Humphries · 2005 · The Lancet
  46. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial
    Jones, M L, Martoni, C J, Prakash, S · 2012 · European Journal of Clinical Nutrition
  47. Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
    Institute of Medicine · 2010 · National Academies Press eBooks
  48. Dietary patterns, inflammation and the metabolic syndrome
    Namanjeet Ahluwalia, Valentina A. Andreeva, Emmanuelle Kesse‐Guyot, Serge Herçberg · 2012 · Diabetes & Metabolism
  49. Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease
    Donald M. Lloyd‐Jones, Kiang Liu, Lü Tian, Philip Greenland · 2006 · Annals of Internal Medicine
  50. Association of Polymorphisms in the CRP Gene With Circulating C-Reactive Protein Levels and Cardiovascular Events
    Lange, Leslie A., Carlson, Christopher S., Hindorff, Lucia A., Lange, Ethan M., Walston, Jeremy, Durda, J. Peter, Cushman, Mary, Bis, Joshua C., Zeng, Donglin, Lin, Danyu et al. · 2006 · JAMA
  51. Inflammation and ischaemic stroke
    Keith W. Muir, Pippa J. Tyrrell, Naveed A. Sattar, Elizabeth A. Warburton · 2007 · Current Opinion in Neurology
  52. Impact of migration on coronary heart disease risk factors: Comparison of Gujaratis in Britain and their contemporaries in villages of origin in India
    Jeetesh V. Patel, Avni Vyas, John Kennedy Cruickshank, Dorairaj Prabhakaran, Elizabeth A. Hughes, K. Srinath Reddy, Mike Mackness, Deepak Bhatnagar, Paul N. Durrington · 2005 · Atherosclerosis
  53. Lipoprotein (a): impact by ethnicity and environmental and medical conditions
    Byambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund · 2015 · Journal of Lipid Research
  54. Ethnic Differences in C-Reactive Protein Concentrations
    Alyson Kelley-Hedgepeth, Donald M. Lloyd‐Jones, Alicia B. Colvin, Karen A. Matthews, Janet M. Johnston, MaryFran R Sowers, Barbara Sternfeld, Richard C. Pasternak, Claudia U. Chae, for the SWAN Investigators · 2008 · Clinical Chemistry
  55. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
    Evanthia Diamanti‐Kandarakis, Thomas Paterakis, Krystallenia Alexandraki, Christina Piperi, Athanasios Aessopos, Ilias Katsikis, Nikolaos L. Katsilambros, George Kreatsas, Dimitrios Panidis · 2006 · Human Reproduction
  56. Prevalence of coronary artery disease risk factors in Iran: a population based survey
    ZN Hatmi, Shadi Tahvildari, A Gafarzadeh Motlag, Ahmad Sabouri Kashani · 2007 · BMC Cardiovascular Disorders
  57. Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?
    Ann DeBord Smith, Chris Patterson, John Yarnell, Ann Rumley, Yoav Ben‐Shlomo, Gordon D O Lowe · 2005 · Circulation
  58. Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
    Stefan Blankenberg, Matthew McQueen, Marek Smieja, Janice Pogue, Cynthia M. Balion, Eva Lonn, Hans J. Rupprecht, Christoph Bickel, Laurence Tiret, François Cambien et al. · 2006 · Circulation
  59. Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice
    Maqsood M. Elahi, Felino Ramon A. Cagampang, Dhea Mukhtar, Frederick W. Anthony, Sunil Kumar Ohri, Mark A. Hanson · 2009 · British Journal Of Nutrition
  60. Effects of Olive Oil on Markers of Inflammation and Endothelial Function—A Systematic Review and Meta-Analysis
    Schwingshackl, Lukas, Christoph, Marina, Hoffmann, Georg · 2015 · Nutrients
  61. Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses
    John P. A. Ioannidis · 2011 · JAMA
  62. Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis
    Emmilia A. Dowlatshahi, Ella A.M. van der Voort, Lidia R. Arends, Tamar E. C. Nijsten · 2013 · British Journal of Dermatology
  63. Risk stratification in critical limb ischemia: Derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data
    Andres S. Schanzer, Jessica L. Mega, Judith L. Meadows, Russell H. Samson, Dennis F. Bandyk, Michael S. Conte · 2008 · Journal of Vascular Surgery
  64. Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: A need for screening tools to target interventions
    Mark Daniel DeBoer · 2012 · Nutrition
  65. SOCIAL NETWORKS AND INFLAMMATORY MARKERS IN THE FRAMINGHAM HEART STUDY
    LOUCKS, ERIC B., SULLIVAN, LISA M., D’AGOSTINO Sr, RALPH B., LARSON, MARTIN G., BERKMAN, LISA F., BENJAMIN, EMELIA J. · 2006 · Journal of Biosocial Science
  66. Endothelial Dysfunction Contributes to Renal Function–Associated Cardiovascular Mortality in a Population with Mild Renal Insufficiency
    Frank Stam, Coen van Guldener, Annemarie Becker‐Commissaris, Jacqueline M. Dekker, Robert J. Heine, L.M. Bouter, Coen D.A. Stehouwer · 2005 · Journal of the American Society of Nephrology
  67. High von Willebrand Factor Levels Increase the Risk of First Ischemic Stroke
    Tamara N. Bongers, Moniek P.M. de Maat, M.P.J. van Goor, Vinod Bhagwanbali, Huub H.D.M. van Vliet, Encarna B. Gómez-García, Diederik W.J. Dippel, Frank W.G. Leebeek · 2006 · Stroke
  68. C-Reactive Protein Gene Polymorphisms, C-Reactive Protein Blood Levels, and Cardiovascular Disease Risk
    Fadi G. Hage, Alexander J. Szalai · 2007 · Journal of the American College of Cardiology
  69. Elevated Interleukin-18 Levels Are Associated With the Metabolic Syndrome Independent of Obesity and Insulin Resistance
    Joseph Hung, B. McQuillan, Caroline Chapman, Peter Lindsay Thompson, John P. Beilby · 2005 · Arteriosclerosis Thrombosis and Vascular Biology
  70. The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis
    Vlado Perkovic, Christine Verdon, Toshiharu Ninomiya, Federica Barzi, Alan Cass, Anushka A Patel, Meg Jardine, Martin Gallagher, Fiona Turnbull, John Philip Chalmers et al. · 2008 · PLoS Medicine
  71. Physical activity, diet, adiposity and female breast cancer prognosis: A review of the epidemiologic literature
    Ruth E. Patterson, Lisa A. Cadmus, Jennifer A. Emond, John P. Pierce · 2010 · Maturitas
  72. C-Reactive Protein and Risk of Cardiovascular Disease in Men and Women From the Framingham Heart Study
    Peter W.F. Wilson, Byung‐Ho Nam, Michael J. Pencina, Ralph B. D’Agostino, Emelia J. Benjamin, Christopher J. O’Donnell · 2005 · Archives of Internal Medicine
  73. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts
    Tina Shah, Juan Pablo Casas, Jackie A. Cooper, Ioanna Tzoulaki, Reecha Sofat, Valerie McCormack, Liam L Smeeth, John Eric Deanfield, Gordon D O Lowe, Ann Rumley et al. · 2008 · International Journal of Epidemiology
  74. Multiple Markers of Inflammation and Weight Status: Cross-sectional Analyses Throughout Childhood
    Asheley Cockrell Skinner, Michael J. Steiner, Frederick W. Henderson, Eliana Miller Perrin · 2010 · PEDIATRICS
  75. Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases
    Biana Godin, Jason H. Sakamoto, Rita Elena Serda, Alessandro Grattoni, Ali Bouamrani, Mauro Ferrari B · 2010 · Trends in Pharmacological Sciences
  76. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective.
    Carmine Zoccali · 2006 · Kidney International
  77. Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
    Alan Chait, Chang Yeop Han, John F. Oram, Jay W. Heinecke · 2005 · Journal of Lipid Research
  78. Nut and Seed Consumption and Inflammatory Markers in the Multi-Ethnic Study of Atherosclerosis
    Rui Jiang, David R. Jacobs, Elizabeth J. Mayer‐Davis, Moysés Szklo, David M. Herrington, Nancy S. Jenny, Richard A. Kronmal, R. Graham Barr · 2005 · American Journal of Epidemiology
  79. Inflammation, obesity and comorbidities: the role of diet
    Mònica Bulló, Patricia Casas‐Agustench, Pilar Amigó‐Correig, Javier Aranceta Bartrina, Jordi Salas‐Salvadó · 2007 · Public Health Nutrition
  80. C-reactive protein is a mediator of cardiovascular disease
    Radjesh J. Bisoendial, S. Matthijs Boekholdt, Menno Vergeer, Erik S.G. Stroes, John J.P. Kastelein · 2010 · European Heart Journal
  81. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality
    Karolina Tuomisto, Pekka Jousilahti, Jouko Sundvall, Pia Pajunen, Veikko V Salomaa · 2006 · Thrombosis and Haemostasis
  82. High-Sensitivity C-Reactive Protein and Risk of Nontraumatic Fractures in the Bruneck Study
    Georg Andreas Schett · 2006 · Archives of Internal Medicine
  83. Genetic Analysis of the Interleukin-18 System Highlights the Role of the Interleukin-18 Gene in Cardiovascular Disease
    Laurence Tiret, Tiphaine Godefroy, Edith Lubos, Viviane Nicaud, David‐Alexandre Trégouët, Sandrine Barbaux, Renate B. Schnabel, Christoph Bickel, Christine Espinola–Klein, Odette Poirier et al. · 2005 · Circulation
  84. Can Apical Periodontitis Modify Systemic Levels of Inflammatory Markers? A Systematic Review and Meta-analysis
    Maximiliano Schünke Gomes, Trevor Charles Blattner, Manoel Sant’Ana Filho, Fabiana Soares Grecca, Fernando Neves Hugo, ASHRAF F. FOUAD, Mark Allan Reynolds · 2013 · Journal of Endodontics
  85. C-reactive Protein is Associated With Sleep Disordered Breathing Independent of Adiposity
    Naresh M. Punjabi, Brock A. Beamer · 2007 · SLEEP
  86. Chapter 5 Proinflammatory cytokines in CRP baseline regulation
    Carita Eklund · 2009 · Advances in clinical chemistry
  87. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach
    Friedhelm Späh · 2008 · British Journal of Dermatology
  88. Inflammatory markers and cardiovascular health in older adults
    Stephen B. Kritchevsky, Matteo Cesari, Marco Pahor · 2005 · Cardiovascular Research
  89. Association of Common <i>CRP</i> Gene Variants with CRP Levels and Cardiovascular Events
    Miller, D. T., Zee, R. Y. L., Suk Danik, J., Kozlowski, P., Chasman, D. I., Lazarus, R., Cook, N. R., Ridker, P. M., Kwiatkowski, D. J. · 2005 · Annals of Human Genetics
  90. An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach
    Bakker, Gertruud CM, van Erk, Marjan J, Pellis, Linette, Wopereis, Suzan, Rubingh, Carina M, Cnubben, Nicole HP, Kooistra, Teake, van Ommen, Ben, Hendriks, Henk FJ · 2010 · The American Journal of Clinical Nutrition
  91. Associations Between Change in Sleep Duration and Inflammation: Findings on C-reactive Protein and Interleukin 6 in the Whitehall II Study
    Ferrie, J. E., Kivimaki, M., Akbaraly, T. N., Singh-Manoux, A., Miller, M. A., Gimeno, D., Kumari, M., Davey Smith, G., Shipley, M. J. · 2013 · American Journal of Epidemiology
  92. High-Sensitivity C-Reactive Protein as Cardiovascular Risk Marker in Patients with Diabetes Mellitus
    Andreas Pfützner, Thomas M. Forst · 2006 · Diabetes Technology & Therapeutics
  93. Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
    Lin, Jennifer S., Evans, Corinne V., Johnson, Eric, Redmond, Nadia, Coppola, Erin L., Smith, Ning · 2018 · JAMA
  94. Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)—Can C-Reactive Protein Be Used to Target Statin Therapy in Primary Prevention?
    Samia Mora, Paul M. Ridker · 2005 · The American Journal of Cardiology
  95. Mediterranean diet, dietary polyphenols and low grade inflammation: results from the MOLI‐SANI study
    Marialaura Bonaccio, George Pounis, Chiara Cerletti, Maria Benedetta Donati, Licia Iacoviello, Giovanni de Gaetano, on behalf of the MOLI‐SANI Study Investigators · 2016 · British Journal of Clinical Pharmacology
  96. CVD risk factors and ethnicity—A homogeneous relationship?
    Nita G. Forouhi, Naveed A. Sattar · 2006 · Atherosclerosis Supplements
  97. Uremia causes endothelial progenitor cell deficiency
    Kirsten de Groot, Ferdinand H. Bahlmann, Johanna Sowa, Jana Koenig, Jan Menne, Hermann G. Haller, Danilo Fliser · 2004 · Kidney International
  98. The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
    Andrew Wilson, Marno Celeste Ryan, Andrew Boyle · 2005 · International Journal of Cardiology
  99. Impact of Physical Activity, Cardiorespiratory Fitness, and Exercise Training on Markers of Inflammation
    Carl J. Lavie, Timothy S. Church, Richard V. Milani, Conrad P. Earnest · 2011 · Journal of Cardiopulmonary Rehabilitation and Prevention
  100. Clinical Factors, But Not C-Reactive Protein, Predict Progression of Calcific Aortic-Valve Disease
    Gian M. Novaro, Ronit Katz, Ronnier J. Aviles, John S. Gottdiener, Mary Cushman, Bruce M. Psaty, Catherine M Otto, Brian P. Griffin · 2007 · Journal of the American College of Cardiology